{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:17:59Z","timestamp":1791220679428,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":59,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642335693","type":"print"},{"value":"9783642335709","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-33570-9_9","type":"book-chapter","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T12:31:22Z","timestamp":1355401882000},"page":"179-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Persistence of Botulinum Neurotoxin Inactivation of Nerve Function"],"prefix":"10.1007","author":[{"given":"Charles B.","family":"Shoemaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Oyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0041-0101(95)00127-1","volume":"34","author":"M Adler","year":"1996","unstructured":"Adler M, Macdonald DA, Sellin LC, Parker GW (1996) Effect of 3, 4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin. Toxicon: Official J Int Soc Toxinology 34:237\u2013249","journal-title":"Toxicon: Official J Int Soc Toxinology"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0041-0101(00)00120-3","volume":"39","author":"M Adler","year":"2001","unstructured":"Adler M, Keller JE, Sheridan RE, Deshpande SS (2001) Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle. Toxicon: Official J Int Soc Toxinology 39:233\u2013243","journal-title":"Toxicon: Official J Int Soc Toxinology"},{"key":"9_CR58","doi-asserted-by":"publisher","unstructured":"Ahnet-Hilger G, M\u00fcnster-Wandowski A, H\u00f6ltje M (2012) Synaptic vesicle proteins: targets and routes for botulinum neurotoxins. doi:10.1007\/978-3-642-33570-9_8","DOI":"10.1007\/978-3-642-33570-9_8"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/0092-8674(94)90360-3","volume":"76","author":"C Aiken","year":"1994","unstructured":"Aiken C, Konner J, Landau NR, Lenburg ME, Trono D (1994) Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853\u2013864","journal-title":"Cell"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0306-4522(90)90109-H","volume":"37","author":"D Angaut-Petit","year":"1990","unstructured":"Angaut-Petit D, Molgo J, Comella JX, Faille L, Tabti N (1990) Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 37:799\u2013808","journal-title":"Neuroscience"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1471-4159.2004.02844.x","volume":"91","author":"S Bade","year":"2004","unstructured":"Bade S, Rummel A, Reisinger C, Karnath T, Ahnert-Hilger G et al (2004) Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates. J Neurochem 91:1461\u20131472","journal-title":"J Neurochem"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/sj.embor.7400278","volume":"5","author":"M Bajohrs","year":"2004","unstructured":"Bajohrs M, Rickman C, Binz T, Davletov B (2004) A molecular basis underlying differences in the toxicity of botulinum serotypes A and E. EMBO Rep 5:1090\u20131095","journal-title":"EMBO Rep"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1016\/S0021-9258(17)37168-5","volume":"269","author":"F Bartels","year":"1994","unstructured":"Bartels F, Bergel H, Bigalke H, Frevert J, Halpern J et al (1994) Specific antibodies against the Zn(2+)-binding domain of clostridial neurotoxins restore exocytosis in chromaffin cells treated with tetanus or botulinum A neurotoxin. J Biol Chem 269:8122\u20138127","journal-title":"J Biol Chem"},{"key":"9_CR57","doi-asserted-by":"publisher","unstructured":"Binz (2012) Clostridial neurotoxin light chains: devices for SNARE cleavage mediated blockade of neurotransmission. doi:10.1007\/978-3-642-33570-9_7","DOI":"10.1007\/978-3-642-33570-9_7"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","volume":"53","author":"MF Brin","year":"1999","unstructured":"Brin MF, Lew MF, Adler CH, Comella CL, Factor SA et al (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53:1431\u20131438","journal-title":"Neurology"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev.ne.04.030181.000313","volume":"4","author":"MC Brown","year":"1981","unstructured":"Brown MC, Holland RL, Hopkins WG (1981) Motor nerve sprouting. Annu Rev Neurosci 4:17\u201342","journal-title":"Annu Rev Neurosci"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ncb0805-758","volume":"7","author":"ZJ Chen","year":"2005","unstructured":"Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7:758\u2013765","journal-title":"Nat Cell Biol"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"15067","DOI":"10.1074\/jbc.M111.224493","volume":"286","author":"S Chen","year":"2011","unstructured":"Chen S, Barbieri JT (2011) Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25. J Biol Chem 286:15067\u201315072","journal-title":"J Biol Chem"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrm1552","volume":"6","author":"A Ciechanover","year":"2005","unstructured":"Ciechanover A (2005) Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 6:79\u201387","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"A de Paiva","year":"1999","unstructured":"de Paiva A, Meunier FA, Molgo J, Aoki KR, Dolly JO (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96:3200\u20133205","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR14","unstructured":"Dolly JO, Lisk G, Foran PG, Meunier F, Mohammed N, O\u2019Sullivan G, de Paiva A (2002) Insights into the extended duration of neuroparalysis by Botulinum Neurotoxin A relative to the other shorter-acting serotypes: differences between motor nerve terminals and cultured neurons. In: Brin MF, Hallett M, Jankovic J (ed) Scientific and therapeutic aspects of Botulinum Toxin. Lippincott Williams and Wilkins, Philadelphia, pp 91\u2013102"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0014-4827(80)90270-0","volume":"126","author":"K Eiklid","year":"1980","unstructured":"Eiklid K, Olsnes S, Pihl A (1980) Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells. Exp Cell Res 126:321\u2013326","journal-title":"Exp Cell Res"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0304-3940(97)13448-6","volume":"224","author":"R Eleopra","year":"1997","unstructured":"Eleopra R, Tugnoli V, Rossetto O, Montecucco C, De Grandis D (1997) Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human. Neurosci Lett 224:91\u201394","journal-title":"Neurosci Lett"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0304-3940(98)00775-7","volume":"256","author":"R Eleopra","year":"1998","unstructured":"Eleopra R, Tugnoli V, Rossetto O, De Grandis D, Montecucco C (1998) Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett 256:135\u2013138","journal-title":"Neurosci Lett"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF00169066","volume":"351","author":"E Erdal","year":"1995","unstructured":"Erdal E, Bartels F, Binscheck T, Erdmann G, Frevert J et al (1995) Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 351:67\u201378","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1073\/pnas.0400229101","volume":"101","author":"E Fernandez-Salas","year":"2004","unstructured":"Fernandez-Salas E, Steward LE, Ho H, Garay PE, Sun SW et al (2004a) Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc Natl Acad Sci U S A 101:3208\u20133213","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 8","key":"9_CR20","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1002\/mds.20006","volume":"19","author":"E Fernandez-Salas","year":"2004","unstructured":"Fernandez-Salas E, Ho H, Garay P, Steward LE, Aoki KR (2004b) Is the light chain subcellular localization an important factor in botulinum toxin duration of action? Mov Disord 19(Suppl 8):S23\u2013S34","journal-title":"Mov Disord"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0014-5793(98)01012-6","volume":"435","author":"AV Ferrer-Montiel","year":"1998","unstructured":"Ferrer-Montiel AV, Gutierrez LM, Apland JP, Canaves JM, Gil A et al (1998) The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking. FEBS Lett 435:84\u201388","journal-title":"FEBS Lett"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1074\/jbc.M209821200","volume":"278","author":"PG Foran","year":"2003","unstructured":"Foran PG, Mohammed N, Lisk GO, Nagwaney S, Lawrence GW et al (2003) Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 278:1363\u20131371","journal-title":"J Biol Chem"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0014-5793(95)00944-5","volume":"372","author":"LM Gutierrez","year":"1995","unstructured":"Gutierrez LM, Canaves JM, Ferrer-Montiel AV, Reig JA, Montal M et al (1995) A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca(2+)-dependent exocytosis in chromaffin cells. FEBS Lett 372:39\u201343","journal-title":"FEBS Lett"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1074\/jbc.272.5.2634","volume":"272","author":"LM Gutierrez","year":"1997","unstructured":"Gutierrez LM, Viniegra S, Rueda J, Ferrer-Montiel AV, Canaves JM et al (1997) A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J Biol Chem 272:2634\u20132639","journal-title":"J Biol Chem"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0022-5193(79)90141-3","volume":"77","author":"JP Hanig","year":"1979","unstructured":"Hanig JP, Lamanna C (1979) Toxicity of botulinum toxin: a stoichiometric model for the locus of its extraordinary potency and persistence at the neuromuscular junction. J Theor Biol 77:107\u2013113","journal-title":"J Theor Biol"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1002\/j.1460-2075.1994.tb06834.x","volume":"13","author":"T Hayashi","year":"1994","unstructured":"Hayashi T, McMahon H, Yamasaki S, Binz T, Hata Y et al (1994) Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J 13:5051\u20135061","journal-title":"EMBO J"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425\u2013479","journal-title":"Annu Rev Biochem"},{"key":"9_CR59","doi-asserted-by":"publisher","unstructured":"Hill KK, Smith TJ (2012) Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. doi:10.1007\/978-3-642-33570-9_1","DOI":"10.1007\/978-3-642-33570-9_1"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1210\/me.12.7.1060","volume":"12","author":"X Huang","year":"1998","unstructured":"Huang X, Wheeler MB, Kang YH, Sheu L, Lukacs GL et al (1998) Truncated SNAP-25 (1\u2013197), like botulinum neurotoxin A, can inhibit insulin secretion from HIT-T15 insulinoma cells. Mol Endocrinol 12:1060\u20131070","journal-title":"Mol Endocrinol"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0041-008X(85)90342-4","volume":"79","author":"JA Kauffman","year":"1985","unstructured":"Kauffman JA, Way JF Jr, Siegel LS, Sellin LC (1985) Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction. Toxicol Appl Pharmacol 79:211\u2013217","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.neuroscience.2005.12.029","volume":"139","author":"JE Keller","year":"2006","unstructured":"Keller JE (2006) Recovery from botulinum neurotoxin poisoning in vivo. Neuroscience 139:629\u2013637","journal-title":"Neuroscience"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0014-5793(99)00948-5","volume":"456","author":"JE Keller","year":"1999","unstructured":"Keller JE, Neale EA, Oyler G, Adler M (1999) Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett 456:137\u2013142","journal-title":"FEBS Lett"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"760142","DOI":"10.1155\/2012\/760142","volume":"2012","author":"G Krautz-Peterson","year":"2012","unstructured":"Krautz-Peterson G, Zhang Y, Chen K, Oyler GA, Feng H et al (2012) Retargeting Clostridium difficile Toxin B to Neuronal Cells as a Potential Vehicle for Cytosolic Delivery of Therapeutic Biomolecules to Treat Botulism. J Toxicol 2012:760142","journal-title":"J Toxicol"},{"key":"9_CR33","doi-asserted-by":"crossref","unstructured":"Kuo CL, Oyler GA, Shoemaker CB (2011) Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination. PLos ONE (in press)","DOI":"10.1371\/journal.pone.0020352"},{"key":"9_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0014-5793(97)01411-7","volume":"419","author":"J Land","year":"1997","unstructured":"Land J, Zhang H, Vaidyanathan VV, Sadoul K, Niemann H et al (1997) Transient expression of botulinum neurotoxin C1 light chain differentially inhibits calcium and glucose induced insulin secretion in clonal beta-cells. FEBS Lett 419:13\u201317","journal-title":"FEBS Lett"},{"key":"9_CR35","doi-asserted-by":"publisher","first-page":"10471","DOI":"10.1073\/pnas.93.19.10471","volume":"93","author":"PP Mehta","year":"1996","unstructured":"Mehta PP, Battenberg E, Wilson MC (1996) SNAP-25 and synaptotagmin involvement in the final Ca(2+)-dependent triggering of neurotransmitter exocytosis. Proc Natl Acad Sci U S A 93:10471\u201310476","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0928-4257(01)00086-9","volume":"96","author":"FA Meunier","year":"2002","unstructured":"Meunier FA, Schiavo G, Molgo J (2002) Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris 96:105\u2013113","journal-title":"J Physiol Paris"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S1044-7431(02)00016-7","volume":"22","author":"FA Meunier","year":"2003","unstructured":"Meunier FA, Lisk G, Sesardic D, Dolly JO (2003) Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation. Molecular and cellular neurosciences 22:454\u2013466","journal-title":"Molecular and cellular neurosciences"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","volume":"79","author":"M Montal","year":"2010","unstructured":"Montal M (2010) Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem 79:591\u2013617","journal-title":"Annu Rev Biochem"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1111\/j.1460-9568.2007.05529.x","volume":"25","author":"L Morbiato","year":"2007","unstructured":"Morbiato L, Carli L, Johnson EA, Montecucco C, Molgo J et al (2007) Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C. Eur J Neurosci 25:2697\u20132704","journal-title":"Eur J Neurosci"},{"key":"9_CR40","doi-asserted-by":"crossref","first-page":"36897","DOI":"10.1074\/jbc.274.52.36897","volume":"274","author":"GA O\u2019Sullivan","year":"1999","unstructured":"O\u2019Sullivan GA, Mohammed N, Foran PG, Lawrence GW, Oliver Dolly J (1999) Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues. J Biol Chem 274:36897\u201336904","journal-title":"J Biol Chem"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1006\/bbrc.1995.2061","volume":"212","author":"H Otto","year":"1995","unstructured":"Otto H, Hanson PI, Chapman ER, Blasi J, Jahn R (1995) Poisoning by botulinum neurotoxin A does not inhibit formation or disassembly of the synaptosomal fusion complex. Biochem Biophys Res Commun 212:945\u2013952","journal-title":"Biochem Biophys Res Commun"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1139\/y99-089","volume":"77","author":"DA Raciborska","year":"1999","unstructured":"Raciborska DA, Charlton MP (1999) Retention of cleaved synaptosome-associated protein of 25\u00a0kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning. Can J Physiol Pharmacol 77:679\u2013688","journal-title":"Can J Physiol Pharmacol"},{"key":"9_CR43","first-page":"120","volume":"61","author":"LC Sellin","year":"1983","unstructured":"Sellin LC, Kauffman JA, Dasgupta BR (1983) Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction. Med biol 61:120\u2013125","journal-title":"Med biol"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jcb.22300","volume":"108","author":"X Shi","year":"2009","unstructured":"Shi X, Curran JE, Liao Z, Gordon RK (2009) The biological activity of ubiquitinated BoNT\/B light chain in vitro and in human SHSY-5Y neuronal cells. J Cell Biochem 108:660\u2013667","journal-title":"J Cell Biochem"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/WNL.49.1.189","volume":"49","author":"RR Sloop","year":"1997","unstructured":"Sloop RR, Cole BA, Escutin RO (1997) Human response to botulinum toxin injection: type B compared with type A. Neurology 49:189\u2013194","journal-title":"Neurology"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.toxicon.2010.07.003","volume":"56","author":"JM Tremblay","year":"2010","unstructured":"Tremblay JM, Kuo CL, Abeijon C, Sepulveda J, Oyler G et al (2010) Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases. Toxicon: Official J Int Soc Toxinology 56:990\u2013998","journal-title":"Toxicon: Official J Int Soc Toxinology"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"16554","DOI":"10.1073\/pnas.1008302107","volume":"107","author":"YC Tsai","year":"2010","unstructured":"Tsai YC, Maditz R, Kuo CL, Fishman PS, Shoemaker CB et al (2010) Targeting botulinum neurotoxin persistence by the ubiquitin-proteasome system. Proc Natl Acad Sci U S A 107:16554\u201316559","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"12142","DOI":"10.1073\/pnas.93.22.12142","volume":"93","author":"A Varshavsky","year":"1996","unstructured":"Varshavsky A (1996) The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci U S A 93:12142\u201312149","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"16993","DOI":"10.1074\/jbc.M710442200","volume":"283","author":"J Wang","year":"2008","unstructured":"Wang J, Meng J, Lawrence GW, Zurawski TH, Sasse A et al (2008) Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics. J Biol Chem 283:16993\u201317002","journal-title":"J Biol Chem"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1074\/jbc.M110.181784","volume":"286","author":"J Wang","year":"2011","unstructured":"Wang J, Zurawski TH, Meng J, Lawrence G, Olango WM et al (2011) A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic. J Biol Chem 286:6375\u20136385","journal-title":"J Biol Chem"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/BJ20120100","volume":"444","author":"J Wang","year":"2012","unstructured":"Wang J, Zurawski TH, Bodeker MO, Meng J, Boddul S et al (2012) Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B. Biochem J 444:59\u201367","journal-title":"Biochem J"},{"key":"9_CR52","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1016\/j.vaccine.2009.05.030","volume":"27","author":"RP Webb","year":"2009","unstructured":"Webb RP, Smith TJ, Wright P, Brown J, Smith LA (2009) Production of catalytically inactive BoNT\/A1 holoprotein and comparison with BoNT\/A1 subunit vaccines against toxin subtypes A1, A2, and A3. Vaccine 27:4490\u20134497","journal-title":"Vaccine"},{"key":"9_CR53","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature06780","volume":"452","author":"TF Westbrook","year":"2008","unstructured":"Westbrook TF, Hu G, Ang XL, Mulligan P, Pavlova NN et al (2008) SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 452:370\u2013374","journal-title":"Nature"},{"key":"9_CR54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7326\/0003-4819-61-3-448","volume":"61","author":"RL Whittaker","year":"1964","unstructured":"Whittaker RL, Gilbertson RB, Garrett AS Jr (1964) Botulism, type E; report of eight simultaneous cases. Ann Intern Med 61:448\u2013454","journal-title":"Ann Intern Med"},{"key":"9_CR55","doi-asserted-by":"crossref","unstructured":"Wong E, Cuervo AM (2010) Integration of clearance mechanisms: the proteasome and autophagy. Cold Spring Harbor perspectives in biology 2:a006734","DOI":"10.1101\/cshperspect.a006734"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0092-8674(78)90099-5","volume":"15","author":"M Yamaizumi","year":"1978","unstructured":"Yamaizumi M, Mekada E, Uchida T, Okada Y (1978) One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 15:245\u2013250","journal-title":"Cell"}],"container-title":["Current Topics in Microbiology and Immunology","Botulinum Neurotoxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-33570-9_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T10:05:11Z","timestamp":1710497111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-33570-9_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642335693","9783642335709"],"references-count":59,"aliases":["10.1007\/978-3-662-45790-0_9"],"URL":"https:\/\/doi.org\/10.1007\/978-3-642-33570-9_9","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"14 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}